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Noninvasive photoacoustic sentinel lymph node SLN mapping with high spatial resolution has the
potential to improve the false negative rate and eliminate the use of radioactive tracers in SLN
identification. In addition, the demonstrated high spatial resolution may enable physicians to replace
SLN biopsy with fine needle aspiration biopsy, and thus reduce the risk of associated morbidity. The
primary goal of this study is to demonstrate the feasibility of high-speed 3D photoacoustic imaging
of the uptake and clearance dynamics of Evans blue dye in SLNs. The photoacoustic imaging
system was developed with a 30 MHz ultrasound array and a kHz repetition rate laser system. It
acquires one 3D photoacoustic image of 166 B-scan frames in 1 s, with axial, lateral, and eleva-
tional resolutions of 25, 70, and 200 m, respectively. With optic-fiber based light delivery, the
entire system is compact and is convenient to use. Upon injection of Evans blue, a blue dye
currently used in clinical SLN biopsy, SLNs in mice and rats were accurately and noninvasively
mapped in vivo using our imaging system. In our experiments, the SLNs were found to be located
at 0.65 mm below the skin surface in mice and 1.2 mm in rats. In some cases, lymph vessels
and lymphatic valves were also imaged. The dye dynamics—accumulation and clearance—in SLNs
were quantitatively monitored by sequential 3D imaging with temporal resolution of as high as
6 s. The demonstrated capability suggests that high-speed 3D photoacoustic imaging should
facilitate the understanding of the dynamics of various dyes in SLNs and potentially help identify
SLNs with high accuracy. © 2009 American Association of Physicists in Medicine.
DOI: 10.1118/1.3168598
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The sentinel lymph node SLN hypothesis, popularized by
Morton et al.1 and Giuliano et al.2 in the early 1990s, states
that it is sufficient to assess lymphatic metastasis by exam-
ining the first tumor-draining sentinel lymph node. Sentinel
lymph node biopsy, based on this concept, has emerged as
the standard of care in breast cancer.3 In SLN biopsy, radio-
active colloids e.g., Tc-99m sulfur colloids are injected pre-
operatively to locate the SLN with a handheld gamma probe,
followed by a blue dye e.g., methylene blue injection to
precisely locate it intraoperatively for dissection. SLN bi-
opsy has greatly reduced unnecessary lymph node dissec-
tions and thus the risk of associated complications e.g.,
lymphedema. However, it also has drawbacks:
• Up to 60 learning cases may be required to develop
technical proficiency,4 in published results without a
high number of learning cases per surgeon, up to 16%
of SLNs were missed5.
• The false negative rate is estimated to be 5% –10%
6,7even in experienced hands.
3724 Med. Phys. 36 „8…, August 2009 0094-2405/2009/36„8• The technique involves radioactive tracer, which re-
quires a separate injection procedure and radiation
safety protections.
• Although less invasive than axillary lymph node dissec-
tion, it still has associated morbidity such as seroma
formation, lymphedema, and sensory nerve injury.8
These drawbacks suggest that alternative strategies for SLN
identification should be explored.
Ultrasound-guided fine needle aspiration biopsy has been
reported as a less invasive alternative to SLN biopsy.9,10 Un-
fortunately, although ultrasound can detect hypoechoic
lymph nodes, it cannot distinguish the sentinel node because
blue dyes have little mechanical contrast. Near infrared fluo-
rescence imaging has been actively explored for SLN
mapping.11–13 This imaging technique performs real-time im-
aging capable of capturing the dynamics in SLNs.14 How-
ever, due to the strong optical scattering in biological tissue,
conventional fluorescence imaging has difficulty in identify-
ing deep SLNs with high spatial resolution. Another chal-
lenge for fluorescence imaging is the relatively low quantum3724…/3724/6/$25.00 © 2009 Am. Assoc. Phys. Med.
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quantum dots have high quantum yield, the issue of potential
toxicity has to be addressed.15
Photoacoustic imaging combines the advantages of excel-
lent optical absorption contrast and high ultrasonic resolution
at great depths, up to a few centimeters.16 Our group recently
demonstrated that photoacoustic imaging with methylene
blue dye injection can accurately identify SLNs at depths of
up to 31 mm in scattering biological tissue in a rat
model.18,19 This depth is greater than the mean SLN depth
distance from the skin surface to the top surface of the SLN
of 125 mm, which was computed from 24 ultrasound
breast images randomly selected from 200 cases taken
over a 3 yr period.17 Given the use of only conventional blue
dye that is already part of the current standard of care, pho-
toacoustic imaging is a promising technology for accurate
SLN mapping, potentially capable of improving the false
negative rate in SLN identification. With the demonstrated
high spatial resolution, it may also have the potential to re-
place SLN biopsy with fine needle aspiration biopsy, and
thus to reduce the risk of associated morbidity.
In photoacoustic imaging with a single-element ultrasonic
transducer, the data acquisition speed is usually limited by
the raster scanning.18,19 Fortunately, this drawback can be
overcome by using an ultrasound array. With a high-
frequency ultrasound array, we recently developed a photoa-
coustic imaging system that performs 50 Hz real-time
B-scan imaging and high-speed 3D imaging—one 3D image
acquisition takes 1 s.20–22 We believe that this imaging speed
is highly desirable in clinics, and it is expected to facilitate
the study of photoacoustic SLN mapping. In this study, we
demonstrated the feasibility of SLN mapping in a murine
model with our refined high-speed 3D photoacoustic imaging
system. Evans blue, a blue dye used in clinical SLN
biopsy,23,24 was employed to provide the optical absorption
contrast with the peak absorption wavelength at 620 nm,
and the two half-maximum wavelengths at 540 and
650 nm, respectively25 for photoacoustic imaging. In addi-
tion, the dye dynamics in SLNs were quantitatively moni-
tored with a 3D imaging temporal resolution of as high as
6 s.
II. MATERIALS AND METHODS
II.A. Imaging system
Figure 1 shows a schematic of the high-speed 3D photoa-
coustic imaging system. While the laser and the imaging
head were fixed on an optical table, all the electronics were
placed on a movable rack, creating a system potentially
transportable to the clinics.
For photoacoustic wave excitation, a tunable dye laser
Cobra, Sirah Laser-und Plasmatechnik GmbH, Germany,
pumped by a Q-switched Nd:YLF laser INNOSLAB, Edge-
wave GmbH, Germany, was used. The Q-switched laser
could be externally triggered up to 1 kHz without compro-
mising pulse energy, which, together with the use of an ul-
trasound array and a multicore computer for parallel beam-
forming, was critical to achieve the high imaging speed. The
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energy of 11 mJ/pulse at 523 nm. The dye laser, with Pyr-
romethene 597 dye, had a peak output at 582 nm and a tun-
able range from 561 to 610 nm. The output energies from
the dye laser at 584 and 600 nm—the two wavelengths used
for the experiments—were 2.5 and 1.5 mJ/pulse, respec-
tively.
The dye laser output was split into two beams and
coupled into two 0.6-mm-core-diameter multimode optic fi-
bers. The light beams from the output end of the optic fibers
were cylindrically focused and delivered to the object to be
imaged. As shown in Fig. 1 inset a, dark-field laser illu-
mination was used to reduce the photoacoustic signals from
the superficial paraxial area.26–29 The optical fluence on the
skin surface of the object was estimated to be
0.5–1.0 mJ /cm2 per pulse, well below the ANSI recom-
mended maximum permissible exposure MPE of
20 mJ /cm2 for a single pulse. The time averaged light inten-
sity during image acquisition was 150–300 mW /cm2, also
below the ANSI recommended MPE calculated by
1.1t0.25 W /cm2 t in seconds.30 As the ANSI safety limit for
this pulse width region is dominantly based on the thermal
mechanism, our compliance with the ANSI standards guar-
antees no thermal damage to the tissue.
We used a unique 30 MHz ultrasound array fabricated
from a 2-2-piezocomposite by the NIH Resource Center for
Medical Ultrasonic Transducer Technology at the University
of Southern California. The array had 48 elements 82 m
2 mm with 100 m spacing. The elements were eleva-
tionally focused at 8.2 mm, providing an elevational reso-
lution of 200 m within the 3.5 mm focal zone. The mean
fractional bandwidth was 50% for pulse-echo operation,
translating to 70% for receiving-only operation, as used in
our present photoacoustic imaging system. The axial and lat-
eral resolutions of the system at 8 mm normal depth from the
transducer surface were 25 and 70 m, respectively.
While cross-sectional B-scan images were obtained by
electronic beamforming using a multicore PC Dell Precision
FIG. 1. Schematic of the high-speed 3D photoacoustic imaging system. Inset
a. Optical illumination pattern on the skin surface.490 with two 2.66 GHz Quad core Xeon processors, 3D
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the array—using a linear motion actuator—in a water con-
tainer Fig. 1. The water container, with dimensions of
853 cm3 had a thin low-density polyethylene membrane
window transparent to light and ultrasound. Acoustic gel was
used for ultrasonic coupling between the membrane and the
object. With this design, there was no direct contact between
the moving imaging head and the object, minimizing poten-
tial perturbations produced by the mechanical scanning.
A high-speed 125 megasamples /s 14-bit 8-channel
DAQ card Octopus CompuScope 8389, GaGe Applied Sys-
tems, USA was used for data acquisition. Because of the 6:1
downmultiplexing in data acquisition, six laser shots were
needed to obtain one B-scan image. The card was used as the
master clock for the entire system and was programed to
send trigger signals to the multiplexer control and laser. The
repetition rate was set at 1 kHz, which was the highest rate
that the laser could reach without degradation of pulse en-
ergy.
To obtain one 3D image, 166 B-scan frames were ac-
quired in 996 ms, corresponding to 996 laser shots at a
1 kHz repetition rate. During the data acquisition, the array
scanned at a constant speed of 10 mm /s. The speed was set
so that the distance the array traveled during each B-scan
was 60 m, less than the 200 m ultrasonic elevational fo-
cus. For sequential 3D image acquisition, the system has a
temporal resolution of 6 s, currently limited by the time for
writing data to the hard drive and postbeamforming after
each 3D data acquisition.
II.B. Animal model and in vivo imaging
Hsd:Athymic Nude mice Harlan Laboratories, Inc.,
USA weighing 18 g and Sprague Dawley rats Harlan
Laboratories, Inc., USA weighing 120 g were used for the
experiments. An intradermal injection of a mixture of ket-
amine 85 mg /kg and xylazine 15 mg /kg was used for
initial anesthesia. For rats, the hair in the axillary region was
removed with commercial hair-removal lotion before imag-
ing. During all image acquisitions, anesthesia was main-
tained using vaporized isoflurane Euthanex Co., USA. The
animals were euthanized by pentobarbital overdose after ex-
periments. All experimental animal procedures were carried
out in compliance with Washington University approved pro-
tocols.
For each experiment, a control photoacoustic image of the
region of interest was acquired before dye injection. Then in
situ intradermal injection of Evans blue dye Sigma-Aldrich
Co., USA was performed on the left forepaw pad. Photoa-
coustic imaging was started immediately after the dye injec-
tion. Thereafter, images were acquired every 8 s for the
initial few minutes; subsequent image acquisitions were done
at longer intervals for a prolonged period, up to 1.5 h. Two
laser wavelengths were used for the experiments: 584 and
600 nm. The former is close to the peak-output wavelength
of the dye laser and was used to image the SLNs and blood
vessels simultaneously—this wavelength also corresponds to
an isosbestic point where oxy- and deoxyhemoglobin have
Medical Physics, Vol. 36, No. 8, August 2009the same optical absorption coefficient. The latter is close to
the absorption peak of Evans blue and was used to image
primarily the SLNs. The goal was to noninvasively identify
the SLNs accurately and meanwhile capture the dye dynam-
ics.
III. RESULTS
A mouse SLN was imaged noninvasively in vivo using the
high-speed photoacoustic imaging system. Figure 2a is a
photograph of the mouse taken before photoacoustic imag-
ing, showing the axillary region. The black tape in the pho-
tograph was used to guide the initial positioning of the im-
aging head. Figure 2b is a photoacoustic control image
acquired at 600 nm, shown in the form of maximum ampli-
tude projection MAP, which was created by projecting the
maximum photoacoustic amplitudes along the depth direc-
tion to the skin surface. A few blood vessels were imaged,
FIG. 2. Noninvasive in vivo photoacoustic mapping of the sentinel lymph
node in a mouse. a Photograph taken before photoacoustic imaging. BT,
black tape, was used to guide the initial positioning. b Control photoacous-
tic MAP image acquired at 600 nm laser wavelength before Evans blue
injection. BV, blood vessel. The color bar represents optical absorption. c
Photoacoustic MAP image acquired at 600 nm 8 s after Evans blue injec-
tion. SLN, sentinel lymph node. LV, lymph vessel. d Control photoacoustic
MAP image acquired at 584 nm. e Photoacoustic MAP image acquired at
584 nm 8 min after Evans blue injection. f Composite photoacoustic MAP
image. g Composite photoacoustic B-scan image corresponding to the dot-
ted line in c, showing the depth of the SLN. SK, skin surface. h Com-
posite 3D photoacoustic image. i Photograph taken with skin removed
after photoacoustic imaging.but the images have low contrast because of the low energy
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sorption at this wavelength.31 Figure 2c is a photoacoustic
MAP image acquired at 600 nm 8 s after injection of
100 g 1%, 0.01 ml Evans blue. The SLN as well as an
afferent lymph vessel are clearly seen. As 600 nm is close to
the Evans blue peak absorption wavelength 620 nm, the
SLN shows excellent contrast in the image. Figure 2d is a
control photoacoustic image acquired at 584 nm, showing
the subcutaneous vasculature. The spatial resolutions are
70 m in the lateral vertical and 200 m in the elevational
horizontal directions, respectively. After Evans blue injec-
tion, both the vasculature and SLN were imaged Fig. 2e.
A composite of the two photoacoustic MAP images acquired
at 600 and 584 nm was obtained Fig. 2f. In this compos-
ite image, the blood vessels and dyed lymphatic system—the
SLN and lymph vessel—are clearly seen with high contrast
and good resolution. The distance between the top surface of
the SLN and the skin surface was estimated to be
65050 m from the composite B-scan image Fig. 2g.
A composite 3D image, constructed with VolView Kitware
Inc., USA, is shown in Fig. 2h. An invasive photograph of
the same mouse, with the skin removed, was taken after pho-
toacoustic imaging Fig. 2i. The SLN was embedded in
fatty tissue, and thus difficult for naked eyes to locate pre-
cisely, even with the skin removed. The dynamic behavior of
Evans blue in the SLN is shown in Fig. 3g mouse 1,
obtained with the aforementioned data acquisition strategy.
Each data point in Fig. 3g was computed as the photoa-
coustic signal averaged over the entire SLN area in the cor-
responding MAP image normalized by the temporal maxi-
mum value of the same SLN. The data points were
exponentially fitted to show the change more clearly. In this
case, the photoacoustic signal was observed to decrease with
time from the first recorded point 8 s and was of 10%
peak value after 1.5 h.
Another mouse was imaged with the same scheme but
with less Evans blue injection—32 g 0.4%, 0.008 ml.
This time, a signal increase was observed within the initial
40 s Figs. 3a–3d, followed by a subsequent decrease
Fig. 3e. A composite B-scan image Fig. 3f along the
dotted line in Fig. 3d was obtained, showing the depth of
the SLN. The quantitative dynamics were plotted in Fig. 3g
mouse 2, showing both a rising and a falling phase.
A rat was also imaged. After taking the control images at
600 nm Fig. 4a and 584 nm Fig. 4b, 300 g 1%,
0.03 ml of Evans blue was injected. In this case, the SLN as
well as a lymphatic valve were identified Fig. 4c. A pho-
toacoustic image taken at 600 nm 15 min after Evans blue
injection showed a sharp signal decrease from the lymphatic
valve, which became barely visible, while the SLN was still
clearly imaged Fig. 4d. A composite image was formed to
show the dyed lymphatic system and the blood vessels Fig.
4e. The composite B-scan image indicates that the SLN is
at a depth of 1.20.1 mm below the skin surface Fig.
4f. The signal from the lymphatic valve decreased with
time from the first recorded data, while the SLN exhibited
Medical Physics, Vol. 36, No. 8, August 2009both a rising phase and a falling phase, showing the dynam-
ics of both dye accumulation and clearance Fig. 4g.
IV. DISCUSSION
Compared to pure optical imaging modalities, photoa-
coustic imaging is known to have high resolution at a greater
imaging depth—beyond the ballistic and quasiballistic re-
gime in scattering biological tissue—with excellent optical
absorption contrast.26,32 It is also a high-speed imaging mo-
dality by nature, with the speed fundamentally limited by the
time of arrival of the photoacoustic waves, which, for ex-
ample, should allow A-line acquisitions at up to 100 kHz rate
at a depth of 1.5 cm. Photoacoustic imaging using a 1D ul-
trasound array eliminates mechanical scanning for B-scan
imaging, which has led to 50 Hz real-time B-scan imaging;
for 3D imaging, linear mechanical scanning is required,
which, however, is still much faster than the raster scanning
required by a system with a single-element ultrasonic trans-
ducer.
Currently, the high-speed photoacoustic imaging system
performs real-time B-scan imaging at 50 Hz and 3D imaging
of 166 B-scan frames at 0.2 Hz, representing the highest
FIG. 3. Evans blue dynamics in the SLN of a mouse monitored by photoa-
coustic imaging. a Control photoacoustic MAP image in a mouse mouse
2 acquired before Evans blue injection. BV, blood vessel. The color bar
represents optical absorption. b–e Photoacoustic MAP images acquired
at 14 s, 22 s, 38 s, and 20 min, respectively, after Evans blue injection. f
Composite photoacoustic B-scan image corresponding to the dotted line in
d. SK, skin surface. g Evans blue dynamics in mice SLNs. Data points
were fitted exponentially. PA, photoacoustic.speed in high-frequency photoacoustic imaging to our
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ited by the data saving and beamforming after each 3D im-
age acquisition. It can be improved by temporarily storing all
3D data in computer memory during the entire data acquisi-
tion without beamforming, or by using a 48-channel DAQ
card to eliminate the multiplexing—then one laser pulse in-
stead of six could produce one B-scan image. We will ex-
plore both directions in the future.
In photoacoustic imaging, the spatial resolution and imag-
ing depth are scalable with the ultrasonic frequency within
the reach of photons.32 With a 3.5 MHz single-element ultra-
sonic transducer and methylene blue dye at a laser wave-
length of 635 nm, photoacoustic imaging was demonstrated
to be capable of imaging SLNs as deep as 31 mm in scatter-
ing biological tissue.18,19 However, a relatively long time
20–40 min was required to acquire one 3D image with that
system. In this study, we demonstrated accurate photoacous-
tic SLN mapping in mice and rats, as well as the capability to
quantify the dye dynamics in SLNs. As the major goal of this
study was to demonstrate the feasibility of capturing the dye
dynamics in SLNs with photoacoustic imaging, the choice of
FIG. 4. Noninvasive in vivo photoacoustic mapping and dynamic monitoring
of the sentinel lymph node in a rat. a Control photoacoustic MAP image
acquired at 600 nm laser wavelength before Evans blue injection. b Con-
trol photoacoustic MAP image acquired at 584 nm, showing the subcutane-
ous vasculature. c Photoacoustic MAP image acquired at 600 nm 6 min
after Evans blue injection. LVv, lymphatic valve; SLN, sentinel lymph node.
d Photoacoustic MAP image acquired at 600 nm 15 min after Evans blue
injection. e Composite photoacoustic MAP image. f Composite photoa-
coustic B-scan image corresponding to the dotted line in c. SK, skin sur-
face. g Evans blue dynamics in the rat lymphatic valve and SLN.the dye Evans blue and wavelength 600 nm, limited by
Medical Physics, Vol. 36, No. 8, August 2009the operating spectral range of our kHz repetition rate laser
system, were not fully optimized for deep imaging. However,
with the feasibility demonstrated in this study, we expect that
a low-frequency ultrasound array e.g., 3–5 MHz and a
high-power laser, operating at a longer wavelength e.g.,
700 nm, will enable photoacoustic imaging to achieve a
sufficient imaging depth 30 mm, while retaining the
high imaging speed. To translate the technology to the clinic,
a high-speed photoacoustic imaging system with a commer-
cial low-frequency ultrasound array is desired. Potentially,
for noninvasive SLN mapping in clinics, such a system can
offer advantages in precision, depth, and speed, and also pro-
vide coregistered complementary ultrasonic images.
V. CONCLUSIONS
SLNs in mice and rats were accurately mapped noninva-
sively in vivo using a high-speed 3D photoacoustic imaging
system with a 30 MHz ultrasound array. The system
achieved a speed for 3D photoacoustic imaging approaching
0.2 Hz, highly desirable in clinics. In addition, the dynamics
of dye accumulation and clearance in the murine SLNs were
quantitatively monitored with a high temporal resolution, up
to 6 s. This capability should facilitate further studies to un-
derstand the dynamics of different dyes in SLNs and poten-
tially help identify SLNs with higher accuracy.
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